Table 2

Clazakizumab PASI scores in psoriatic arthritis

n (%)Placebo
(n=41)
Clazakizumab
25 mg (n=41)
Clazakizumab
100 mg (n=42)
Clazakizumab
200 mg (n=41)
Week 16
 PASI 756 (14.6)5 (12.2)7 (16.7)2 (4.9)
 PASI 5015 (36.6)14 (34.1)13 (31.0)8 (19.5)
Week 24
 PASI 755 (12.2)8 (19.5)12 (28.6)5 (12.2)
 PASI 5012 (29.3)17 (41.5)16 (38.1)10 (24.4)
  • PASI, psoriasis area severity index.